These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16137544)

  • 1. The role of the kidney in cardiovascular medicine.
    Ritz E
    Eur J Intern Med; 2005 Sep; 16(5):321-7. PubMed ID: 16137544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney and hypertension-causes. Update 2003.
    Ritz E; Adamczak M; Zeier M
    Herz; 2003 Dec; 28(8):663-7. PubMed ID: 14689099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease.
    Lawson CR; Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):139-45. PubMed ID: 17094050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talk between the kidney and the cardiovascular system.
    Amann K; Wanner C; Ritz E
    J Am Soc Nephrol; 2006 Aug; 17(8):2112-9. PubMed ID: 16825329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive therapy in the presence of proteinuria.
    Sarafidis PA; Khosla N; Bakris GL
    Am J Kidney Dis; 2007 Jan; 49(1):12-26. PubMed ID: 17185142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of blood pressure control in chronic kidney disease.
    Ravera M; Re M; Deferrari L; Vettoretti S; Deferrari G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S98-103. PubMed ID: 16565257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can we influence the progression of chronic kidney disease?].
    Kuhlmann U; Hoyer J
    Urologe A; 2009 Jul; 48(7):793-803; quiz 804-5. PubMed ID: 19590915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure.
    Carey RM; Padia SH
    Trends Endocrinol Metab; 2008 Apr; 19(3):84-7. PubMed ID: 18294862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
    Dussol B; Berland Y
    Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered regulation of renal interstitial hydrostatic pressure and the renal renin-angiotensin system in the absence of atrial natriuretic peptide.
    O'Tierney PF; Komolova M; Tse MY; Adams MA; Pang SC
    J Hypertens; 2008 Feb; 26(2):303-11. PubMed ID: 18192845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring.
    Agarwal R
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):309-13. PubMed ID: 16609300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and extrarenal mechanisms of perinatal programming after intrauterine growth restriction.
    Dötsch J
    Hypertens Res; 2009 Apr; 32(4):238-41. PubMed ID: 19262494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting genes in the renin-angiotensin system.
    Le TH; Coffman TM
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):57-63. PubMed ID: 18090671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.